Trikafta Treatment Clears Aspergillus Fungus in CF: Pilot Study
Trikafta, a triple therapy combining elexacaftor, tezacaftor, and ivacaftor, cleared Aspergillus fungus in the lungs and prevented severe infections in children and adults with cystic fibrosis (CF), a pilot study found. “These preliminary results are very encouraging and support the hypothesis that initiation of [Trikafta] therapy rapidly improves…